195 related articles for article (PubMed ID: 18267012)
1. La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.
Bennett RS; Cress CM; Ward JM; Firestone CY; Murphy BR; Whitehead SS
Virol J; 2008 Feb; 5():25. PubMed ID: 18267012
[TBL] [Abstract][Full Text] [Related]
2. A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.
Bennett RS; Gresko AK; Nelson JT; Murphy BR; Whitehead SS
J Virol; 2012 Jan; 86(1):420-6. PubMed ID: 22013033
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent myeloid dendritic cell responses mediate resistance to la crosse virus-induced neurological disease.
Taylor KG; Woods TA; Winkler CW; Carmody AB; Peterson KE
J Virol; 2014 Oct; 88(19):11070-9. PubMed ID: 25008929
[TBL] [Abstract][Full Text] [Related]
4. Tahyna virus genetics, infectivity, and immunogenicity in mice and monkeys.
Bennett RS; Gresko AK; Murphy BR; Whitehead SS
Virol J; 2011 Mar; 8():135. PubMed ID: 21435229
[TBL] [Abstract][Full Text] [Related]
5. Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes.
Bennett RS; Ton DR; Hanson CT; Murphy BR; Whitehead SS
Virol J; 2007 May; 4():41. PubMed ID: 17488515
[TBL] [Abstract][Full Text] [Related]
6. DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells.
Schuh T; Schultz J; Moelling K; Pavlovic J
Hum Gene Ther; 1999 Jul; 10(10):1649-58. PubMed ID: 10428210
[TBL] [Abstract][Full Text] [Related]
7. La Crosse viremias in Mongolian gerbils (Meriones unguiculatis).
Osorio JE; Yuill TM
Am J Trop Med Hyg; 1996 Nov; 55(5):567-9. PubMed ID: 8940992
[TBL] [Abstract][Full Text] [Related]
8. Lymphocytes have a role in protection, but not in pathogenesis, during La Crosse Virus infection in mice.
Winkler CW; Myers LM; Woods TA; Carmody AB; Taylor KG; Peterson KE
J Neuroinflammation; 2017 Mar; 14(1):62. PubMed ID: 28340587
[TBL] [Abstract][Full Text] [Related]
9. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts.
Blakqori G; Delhaye S; Habjan M; Blair CD; Sánchez-Vargas I; Olson KE; Attarzadeh-Yazdi G; Fragkoudis R; Kohl A; Kalinke U; Weiss S; Michiels T; Staeheli P; Weber F
J Virol; 2007 May; 81(10):4991-9. PubMed ID: 17344298
[TBL] [Abstract][Full Text] [Related]
10. Innate immune response to La Crosse virus infection.
Taylor KG; Peterson KE
J Neurovirol; 2014 Apr; 20(2):150-6. PubMed ID: 23846288
[TBL] [Abstract][Full Text] [Related]
11. Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.
Pekosz A; Griot C; Stillmock K; Nathanson N; Gonzalez-Scarano F
J Virol; 1995 Jun; 69(6):3475-81. PubMed ID: 7745694
[TBL] [Abstract][Full Text] [Related]
12. Effects of La Crosse virus infection on pregnant domestic rabbits and mongolian gerbils.
Osorio JE; Schoepp RJ; Yuill TM
Am J Trop Med Hyg; 1996 Oct; 55(4):384-90. PubMed ID: 8916793
[TBL] [Abstract][Full Text] [Related]
13. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
[TBL] [Abstract][Full Text] [Related]
14. Human neural stem cell-derived neuron/astrocyte co-cultures respond to La Crosse virus infection with proinflammatory cytokines and chemokines.
Dawes BE; Gao J; Atkins C; Nelson JT; Johnson K; Wu P; Freiberg AN
J Neuroinflammation; 2018 Nov; 15(1):315. PubMed ID: 30442185
[TBL] [Abstract][Full Text] [Related]
15. La Crosse Virus Infection of Human Keratinocytes Leads to Interferon-Dependent Apoptosis of Bystander Non-Infected Cells In Vitro.
Cruz MA; Parks GD
Viruses; 2020 Feb; 12(3):. PubMed ID: 32106552
[TBL] [Abstract][Full Text] [Related]
16. Targeted Mutations in the Fusion Peptide Region of La Crosse Virus Attenuate Neuroinvasion and Confer Protection against Encephalitis.
Hollidge BS; Salzano MV; Ibrahim JM; Fraser JW; Wagner V; Leitner NE; Weiss SR; Weber F; González-Scarano F; Soldan SS
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891445
[TBL] [Abstract][Full Text] [Related]
17. Effect of mixed infections of Sindbis and La Crosse viruses on replication of each virus in vitro.
Bara JJ; Muturi EJ
Acta Trop; 2014 Feb; 130():71-5. PubMed ID: 24463260
[TBL] [Abstract][Full Text] [Related]
18. Capillaries in the olfactory bulb but not the cortex are highly susceptible to virus-induced vascular leak and promote viral neuroinvasion.
Winkler CW; Race B; Phillips K; Peterson KE
Acta Neuropathol; 2015 Aug; 130(2):233-45. PubMed ID: 25956408
[TBL] [Abstract][Full Text] [Related]
19. La Crosse encephalitis surveillance using single versus paired serologic testing.
Murphree R; Dunn JR; Schaffner W; Jones TF
Zoonoses Public Health; 2012 May; 59(3):181-3. PubMed ID: 21848528
[TBL] [Abstract][Full Text] [Related]
20. The CARD9-Associated C-Type Lectin, Mincle, Recognizes La Crosse Virus (LACV) but Plays a Limited Role in Early Antiviral Responses against LACV.
Monteiro JT; Schön K; Ebbecke T; Goethe R; Ruland J; Baumgärtner W; Becker SC; Lepenies B
Viruses; 2019 Mar; 11(3):. PubMed ID: 30917612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
